查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1324784

全球一次性生物加工市场 - 展望与预测（2023-2028）

Single-use Bioprocessing Market - Global Outlook & Forecast 2023-2028
出版日期: | 出版商: Arizton Advisory & Intelligence | 英文 395 Pages | 订单完成后即时交付

价格
简介目录

2022 年至 2028 年，全球一次性生物加工市场规模预计将以 19.74% 的复合年增长率增长。

技术进步是在全球范围内推出新型一次性生物加工耗材的关键。 一次性生物加工市场的参与者推出了新产品，使一次性生物加工比以往更安全、更容易、更高效。 由于这些因素，公司通过满足市场需求来赢得市场份额。 市场参与者正在申请专利，以保护一次性生物工艺产品的新颖设计。 一次性技术在生产应用中的可用性不断提高以及新产品的推出创造了一个环境，使公司可以快速轻鬆地采用该技术并开始获得收益。 公司现在可以通过用一次性技术取代传统的劳动密集型方法来降低成本并提高生产过程的效率。

战略性收购一次性技术可加速生物製药领域的采用。 一次性技术是一种经济高效的方法，可以简化操作、减少浪费并改善质量控制。 通过战略性地获取高质量的一次性技术，公司可以提高竞争优势，同时降低成本并提高效率。 战略性收购一次性技术可提高流程可视性和控制力，从而提高透明度和对行业法规的合规性。 对于寻求降低成本、提高效率和提高竞争优势的组织来说，战略性收购一次性技术可以成为一个强大的工具。 此外，行业参与者正在采取合作伙伴战略，以促进进入区域一次性生物加工市场。

生物製造能力的提高以及生物製药和生物仿製药的使用正在推动一次性生物加工市场的发展。 一次性生物加工为生物製药、生物治疗药物、疫苗、单克隆抗体和生物仿製药的生产提供了一个有价值的平台。 随着生物製造的进步，一次性生物加工提供了更大的灵活性、更短的处理时间、更高的可扩展性、更低的资本成本和更低的产品污染风险。 此外，一次性生物加工还可以降低运营成本，因为不需要对设备进行大量清洁和消毒。

本报告调查了全球一次性生物加工市场，并提供市场概况、按产品类型、应用、最终用户、技术、工作流程、区域和市场渗透率划分的趋势。我们提供公司简介等。

目录

第一章研究方法

第二章调查目的

第三章调查流程

第 4 章范围和适用性

  • 市场定义
  • 基准年
  • 调查范围

第 5 章报告先决条件和註释

第 6 章重要注意事项

第七章市场概述

第 8 章简介

第 9 章市场机会和趋势

  • 细胞和基因治疗中的一次性技术
  • 生物加工的需求不断增加
  • 一次性生物加工技术的进步（子）
  • 新产品发布
  • 增加战略收购和合作

第10章市场增长促进因素

第十一章市场增长制约因素

第十二章市场情况

  • 市场概览
  • 市场规模和预测
  • 市场机会
    • 按产品划分的市场
    • 按应用划分的市场
    • 按最终用户划分的市场
    • 按方法划分的市场
    • 按工作流程进行市场营销
    • 区域市场
  • 五力分析

第十三章产品类型

  • 市场概况和增长动力
  • 市场概览
  • 一次性生物加工设备
  • 简单/外围设备

第14章应用

  • 市场概况和增长动力
  • 市场概览
  • 单克隆抗体
  • 疫苗
  • 细胞疗法
  • 其他

第 15 章最终用户

  • 市场概况和增长动力
  • 市场概览
  • 生物製药製造商
  • 合同製造组织 (CMO)
  • 研发公司/研究机构

第 16 章方法论

  • 市场概况和增长动力
  • 市场概览
  • 过滤
  • 储存和运输
  • 细胞培养
  • 混合物
  • 细化

第 17 章工作流程

  • 市场概况和增长动力
  • 市场概览
  • 上游
  • 下游

第18章区域

第十九章北美

第 20 章欧洲

第 21 章亚太地区

第 22 章拉丁美洲

第 23 章中东和非洲

第24章竞争格局

  • 比赛概览
  • 市场份额分析
    • THERMO FISHER SCIENTIFIC
    • SARTORIUS STEDIM BIOTECH
    • DANAHER
    • MERCK KGAA
    • AVANTOR

第25章主要公司简介

  • THERMO FISHER SCIENTIFIC
  • SARTORIUS STEDIM BIOTECH
  • DANAHER
  • MERCK KGAA
  • AVANTOR

第 26 章其他着名供应商

  • 3I GROUP
  • 3M
  • ABEC
  • ADOLF KUHNER
  • ADVANTAPURE
  • BARRY-WEHMILLER COMPANIES
  • BROADLEY-JAMES
  • CELLTAINER BIOTECH
  • CERCELL A/S
  • CESCO BIOENGINEERING
  • CHARTER MEDICAL
  • COLDER PRODUCTS COMPANY
  • CORNING
  • DISTEK
  • DRM, DR. MUELLER
  • EMERSON ELECTRIC
  • ENTEGRIS
  • EPPENDORF
  • FOXX LIFE SCIENCES
  • GETINGE
  • HIGH-PURITY NEW ENGLAND
  • HOLLAND APPLIED TECHNOLOGIES
  • LONZA
  • MEISSNER FILTRATION PRODUCTS
  • NEW HORIZON BIOTECH
  • OMNIBRX BIOTECHNOLOGIES
  • PARKER HANNIFIN
  • PENDOTECH
  • PBS BIOTECH
  • REPLIGEN
  • SAINT-GOBAIN
  • SENTINEL PROCESS SYSTEMS
  • SOLARIS BIOTECHNOLOGY
  • SYSBIOTECH
  • WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
  • WEIGAO GROUP
  • W.L. GORE & ASSOCIATES

第 27 章报告概述

第 28 章定量概述

第29章附录

简介目录
Product Code: ARZ230614

The global single-use bioprocessing market is expected to grow at a CAGR of 19.74% from 2022 to 2028.

MARKET TRENDS & DRIVERS

New Product Launches

Technological advances have been key in introducing new single-use bioprocess consumables worldwide. Players in the single-use bioprocessing market have launched new products that make single-use bioprocessing safer, easier, and more efficient than ever before. Such factors have allowed companies to gain market share by meeting market demands. Market participants apply for patents on single-use disposable bioprocessing products that protect novel designs. The increasing availability of single-use technology for production applications and the launch of new products creates an environment where companies can quickly and easily adopt the technology and begin reaping the benefits. Companies can now reduce costs and improve efficiency in their production processes by replacing traditional, labor-intensive methods with single-use technology.

Increasing Strategic Acquisitions and Collaborations

The strategic acquisition of single-use technology can enhance adoption across biopharmaceuticals. Single-use technology is a cost-effective and efficient way to streamline operations, reduce waste, and improve quality control. By strategically acquiring high-quality single-use technology, organizations can increase their competitive advantage while reducing costs and increasing efficiency. The strategic acquisition of single-use technology can increase the visibility and control of processes, resulting in increased transparency and compliance with industry regulations. The strategic acquisition of single-use technology can be a powerful tool for organizations looking to reduce costs, increase efficiency, and improve their competitive advantage. In addition, the industry players are adopting partnership strategies to facilitate access to local single-use bioprocessing markets.

Growing Biomanufacturing Capacity and Uptake of Biopharmaceuticals & Biosimilars

The growing biomanufacturing capacity and uptake of biopharmaceuticals and biosimilars drive the single-use bioprocessing market. Single-use bioprocessing provides a valuable platform for producing biopharmaceuticals, biotherapeutics, vaccines, monoclonal antibodies, and biosimilars. With advances in biomanufacturing, single-use bioprocessing offers greater flexibility, shorter process times, improved scalability, lower capital costs, and reduced product contamination risks. Additionally, single-use bioprocessing eliminates the need for extensive cleaning and sterilization of equipment, thus reducing operational costs.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

Single-use bioprocessing equipment is a technology that has revolutionized the biopharmaceutical industry. This technology has increased efficiency, flexibility, safety, and cost savings during bioprocessing. Single-use bioprocessing equipment is a system of technologies designed to replace reusable stainless steel and other materials traditionally used in bioprocessing. This equipment uses single-use components, including bags, bioreactors, tubing, syringes, connectors, and filters, disposed of after use. In 2022, the single-use bioprocessing equipment product type held a larger share of the global single-use bioprocessing market.

Segmentation by Product Type

  • Single-use Bioprocessing Equipment
  • Simple & Peripheral Devices

INSIGHTS BY APPLICATION

The global single-use bioprocessing market by application is segmented as monoclonal antibodies (mABs), vaccines, cell therapies, and others. Monoclonal antibodies (mABs) hold the largest industry share by application segment. Single-use bioprocessing is an emerging technology in the biopharmaceutical industry that has revolutionized how monoclonal antibodies (mAbs) are produced. Single-use bioprocessing involves using disposable bioreactors and other components to produce proteins, such as mAbs. Unlike traditional stainless-steel bioreactors, single-use bioreactors can be quickly set up, require minimal cleaning, and reduce the risk of cross-contamination. Due to their complexity and high cost, these advantages make single-use bioprocessing particularly attractive for mAb production.

Segmentation by Application

  • Monoclonal Antibodies (mABs)
  • Vaccines
  • Cell Therapies
  • Others

INSIGHTS BY END-USER

The biopharmaceutical manufacturers segment accounted for over 39% of the global single-use bioprocessing market. This segment dominates the overall market and will likely retain its dominance in the coming years due to its widespread adoption in research and commercial manufacturing applications. Several biopharmaceutical manufacturers have already explored SUB solutions usage in commercial manufacturing. However, their potential benefits are significant, particularly in small-volume manufacturing in modular facilities. Most biopharmaceutical manufacturers, especially large and medium-sized companies, spend over $50 million on equipment annually. It has been witnessed that a high percentage of capital is being spent on single-use bioprocessing by biopharmaceutical manufacturers.

Segmentation by End-users

  • Biopharmaceutical Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • R&D Companies & Research Institutes

INSIGHTS BY METHOD

The global single-use bioprocessing market by the method is categorized as filtration, storage & transport, cell culture, mixing, and purification. Filtration holds the largest share of the market. Single-use bioprocessing is a method of filtration that has grown increasingly popular in the biotechnology industry. It involves using disposable, self-contained systems to prepare, filter, and process bioproducts. This form of filtration has many advantages, especially for pharmaceutical and biological product manufacturing. Single-use bioprocessing has revolutionized the biotechnology industry. This reduces the need for traditional equipment and infrastructure, resulting in cost savings and improved production efficiency.

Segmentation by Method

  • Filtration
  • Storage & Transport
  • Cell Culture
  • Mixing
  • Purification

INSIGHTS BY WORKFLOW

The upstream workflow segment dominated the global single-use bioprocessing market. Upstream single-use bioprocessing workflow is focused on upstream unit operations such as cell culture, protein expression, and harvest. Over the last decade, advances in this workflow have enabled biopharmaceutical companies to streamline the process, increase product yields, and reduce costs. The upstream single-use bioprocessing workflow advancements have provided biopharmaceutical companies with a more efficient and cost-effective workflow.

Segmentation by Workflow

  • Upstream
  • Downstream

GEOGRAPHICAL ANALYSIS

The single-use bioprocessing market in North America is growing significantly and is expected to grow at a similar pace during the forecast period. Increasing demand for biologics from patients, especially the elderly, high investments in R&D activities by biopharmaceutical companies, and patent expiries of biologics are the key drivers for the single-use bioprocessing market in North America. North America, especially the U.S., is known for its in-house biopharmaceutical manufacturing facilities, which have bolstered the adoption of disposables (simple and peripheral devices) and highly advanced single-use systems such as mixing systems, bioreactors, and cell culture systems over the past few years.

Segmentation by Geography

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Switzerland
    • The U.K.
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • Australia
    • South Korea
    • India
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • South Africa

VENDOR LANDSCAPE

The global single-use bioprocessing market is highly dynamic and offers significant growth opportunities for vendors. Although the industry is characterized by the presence of several global as well as local players, a few major global players hold significant shares, offering a broad range of SUTs. As the market offers tremendous growth opportunities, new players are expected to enter, intensifying the competition. Rising competition among SUT manufacturers is expected to drive significant product development, such as providing single-use bioreactors with large manufacturing volumes and capacities.

Key Company Profiles

  • Thermo Fisher Scientific
  • Sartorius Stedim Biotech
  • Danaher
  • Merck KGaA
  • Avantor

Other Prominent Vendors

  • 3i Group
  • 3M
  • ABEC
  • Adolf Kuhner
  • AdvantaPure
  • Barry-Wehmiller Companies
  • Broadley-James
  • Celltainer Biotech
  • CerCell A/S
  • CESCO Bioengineering
  • Charter Medical
  • Colder Products Company
  • Corning
  • Distek
  • DrM, Dr. Mueller
  • Emerson Electric
  • Entegris
  • Eppendorf
  • Foxx Life Sciences
  • Getinge
  • HIGH PURITY NEW ENGLAND
  • Holland Applied Technologies
  • Lonza
  • MEISSNER FILTRATION PRODUCTS
  • New Horizon Biotech
  • OmniBRx Biotechnologies
  • PARKER HANNIFIN
  • PendoTECH
  • PBS Biotech
  • Repligen
  • Saint-Gobain
  • Sentinel Process Systems
  • Solaris Biotechnology
  • SYSBIOTECH GmbH
  • Watson-Marlow Fluid Technology Solutions
  • Weigao Group
  • W.L. Gore & Associates

KEY QUESTIONS ANSWERED:

  • 1. How big is the global single-use bioprocessing market?
  • 2. What is the growth rate of the single-use bioprocessing market?
  • 3. What are the rising trends in the single-use bioprocessing market?
  • 4. Which region holds the most significant global single-use bioprocessing market share?
  • 5. Who are the key players in the global single-use bioprocessing market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY PRODUCT
    • 4.3.2 MARKET SEGMENTATION BY APPLICATION
    • 4.3.3 MARKET SEGMENTATION BY END-USERS
    • 4.3.4 MARKET SEGMENTATION BY METHOD
    • 4.3.5 MARKET SEGMENTATION BY WORKFLOW
    • 4.3.6 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

  • 6.1 MARKET OVERVIEW
    • 6.1.1 GEOGRAPHY INSIGHTS
    • 6.1.2 PRODUCT TYPE INSIGHTS
    • 6.1.3 APPLICATION INSIGHTS
    • 6.1.4 END-USER INSIGHTS
    • 6.1.5 METHOD INSIGHTS
    • 6.1.6 WORKFLOW INSIGHTS

7 MARKET AT A GLANCE

8 INTRODUCTION

  • 8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 SINGLE-USE TECHNOLOGY IN CELL AND GENE THERAPY
  • 9.2 INCREASING DEMAND FOR CONTINUOUS BIOPROCESSING
  • 9.3 TECHNOLOGICAL ADVANCES IN SINGLE-USE BIOPROCESSING (SUB)
  • 9.4 NEW PRODUCT LAUNCHES
  • 9.5 INCREASING STRATEGIC ACQUISITIONS AND COLLABORATIONS

10 MARKET GROWTH ENABLERS

  • 10.1 GROWING BIOMANUFACTURING CAPACITY AND UPTAKE OF BIOPHARMACEUTICALS & BIOSIMILARS
  • 10.2 LOWER CAPITAL INVESTMENT IN SUTS OVER MULTI-USE PLATFORMS AND LESS FLOOR SPACE REQUIREMENTS
  • 10.3 INCREASED ACCEPTANCE OF SUS TO ENHANCE BIOMANUFACTURING PRODUCTIVITY AND EFFICIENCY
  • 10.4 REDUCED WATER CONSUMPTION AND LESSER ENVIRONMENTAL IMPACT OF SINGLE-USE TECHNOLOGIES

11 MARKET RESTRAINTS

  • 11.1 THE CHANGING SCALE OF SINGLE-USE OPERATIONS
  • 11.2 LOW STRENGTH OF SUPPLY CHAIN AND LACK OF STANDARDIZATION
  • 11.3 ISSUES RELATED TO LEACHABLES AND EXTRACTABLES

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
  • 12.3 MARKET OPPORTUNITY
    • 12.3.1 MARKET BY PRODUCT
    • 12.3.2 MARKET BY APPLICATION
    • 12.3.3 MARKET BY END-USER
    • 12.3.4 MARKET BY METHOD
    • 12.3.5 MARKET BY WORKFLOW
    • 12.3.6 MARKET BY GEOGRAPHY
  • 12.4 FIVE FORCES ANALYSIS
    • 12.4.1 THREAT OF NEW ENTRANTS
    • 12.4.2 BARGAINING POWER OF SUPPLIERS
    • 12.4.3 BARGAINING POWER OF BUYERS
    • 12.4.4 THREAT OF SUBSTITUTES
    • 12.4.5 COMPETITIVE RIVALRY

13 PRODUCT TYPE

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 SINGLE-USE BIOPROCESSING EQUIPMENT
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 SINGLE-USE BIOPROCESSING EQUIPMENT MARKET BY GEOGRAPHY
  • 13.4 SIMPLE & PERIPHERAL DEVICES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 SIMPLE & PERIPHERAL DEVICES MARKET BY GEOGRAPHY

14 APPLICATION

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 MONOCLONAL ANTIBODIES
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MONOCLONAL ANTIBODIES (MABS) MARKET BY GEOGRAPHY
  • 14.4 VACCINES
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 VACCINES MARKET BY GEOGRAPHY
  • 14.5 CELL THERAPIES
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 CELL THERAPIES MARKET BY GEOGRAPHY
  • 14.6 OTHERS
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 OTHERS MARKET BY GEOGRAPHY

15 END-USER

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 BIOPHARMACEUTICAL MANUFACTURERS
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 BIOPHARMACEUTICAL MANUFACTURERS MARKET BY GEOGRAPHY
  • 15.4 CONTRACT MANUFACTURING ORGANIZATIONS (CMO)
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET BY GEOGRAPHY
  • 15.5 R&D COMPANIES AND RESEARCH INSTITUTES
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
    • 15.5.3 R&D COMPANIES AND RESEARCH INSTITUTES MARKET BY GEOGRAPHY

16 METHOD

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 FILTRATION
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
  • 16.4 STORAGE & TRANSPORT
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
  • 16.5 CELL CULTURE
    • 16.5.1 MARKET OVERVIEW
    • 16.5.2 MARKET SIZE & FORECAST
  • 16.6 MIXING
    • 16.6.1 MARKET OVERVIEW
    • 16.6.2 MARKET SIZE & FORECAST
  • 16.7 PURIFICATION
    • 16.7.1 MARKET OVERVIEW
    • 16.7.2 MARKET SIZE & FORECAST

17 WORKFLOW

  • 17.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 17.2 MARKET OVERVIEW
  • 17.3 UPSTREAM
    • 17.3.1 MARKET OVERVIEW
    • 17.3.2 MARKET SIZE & FORECAST
  • 17.4 DOWNSTREAM
    • 17.4.1 MARKET OVERVIEW
    • 17.4.2 MARKET SIZE & FORECAST

18 GEOGRAPHY

  • 18.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 18.2 GEOGRAPHIC OVERVIEW

19 NORTH AMERICA

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
    • 19.2.1 NORTH AMERICA MARKET BY PRODUCT TYPE
    • 19.2.2 NORTH AMERICA MARKET BY APPLICATION
    • 19.2.3 NORTH AMERICA MARKET BY END-USER
  • 19.3 KEY COUNTRIES
    • 19.3.1 US: MARKET SIZE & FORECAST
    • 19.3.2 CANADA: MARKET SIZE & FORECAST

20 EUROPE

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
    • 20.2.1 EUROPE MARKET BY PRODUCT TYPE
    • 20.2.2 EUROPE MARKET BY APPLICATION
    • 20.2.3 EUROPE MARKET BY END-USER
  • 20.3 KEY COUNTRIES
    • 20.3.1 GERMANY: MARKET SIZE & FORECAST
    • 20.3.2 FRANCE: MARKET SIZE & FORECAST
    • 20.3.3 SWITZERLAND: MARKET SIZE & FORECAST
    • 20.3.4 UK: MARKET SIZE & FORECAST
    • 20.3.5 ITALY: MARKET SIZE & FORECAST
    • 20.3.6 SPAIN: MARKET SIZE & FORECAST

21 APAC

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
    • 21.2.1 APAC MARKET BY PRODUCT TYPE
    • 21.2.2 APAC MARKET BY APPLICATION
    • 21.2.3 APAC MARKET BY END-USER
  • 21.3 KEY COUNTRIES
    • 21.3.1 CHINA: MARKET SIZE & FORECAST
    • 21.3.2 JAPAN: MARKET SIZE & FORECAST
    • 21.3.3 AUSTRALIA: MARKET SIZE & FORECAST
    • 21.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 21.3.5 INDIA: MARKET SIZE & FORECAST

22 LATIN AMERICA

  • 22.1 MARKET OVERVIEW
  • 22.2 MARKET SIZE & FORECAST
    • 22.2.1 LATIN AMERICA MARKET BY PRODUCT TYPE
    • 22.2.2 LATIN AMERICA MARKET BY APPLICATION
    • 22.2.3 LATIN AMERICA MARKET BY END-USER
  • 22.3 KEY COUNTRIES
    • 22.3.1 BRAZIL: MARKET SIZE & FORECAST
    • 22.3.2 MEXICO: MARKET SIZE & FORECAST
    • 22.3.3 COLOMBIA: MARKET SIZE & FORECAST
    • 22.3.4 ARGENTINA: MARKET SIZE & FORECAST

23 MIDDLE EAST & AFRICA

  • 23.1 MARKET OVERVIEW
  • 23.2 MARKET SIZE & FORECAST
    • 23.2.1 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
    • 23.2.2 MIDDLE EAST & AFRICA MARKET BY APPLICATION
    • 23.2.3 MIDDLE EAST & AFRICA MARKET BY END-USER
  • 23.3 KEY COUNTRIES
    • 23.3.1 TURKEY: MARKET SIZE & FORECAST
    • 23.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 23.3.3 UAE: MARKET SIZE & FORECAST
    • 23.3.4 SOUTH AFRICA: MARKET SIZE & FORECAST

24 COMPETITIVE LANDSCAPE

  • 24.1 COMPETITION OVERVIEW
    • 24.1.1 VENDOR ACTIVITIES IN SINGLE-USE BIOPROCESSING MARKET
  • 24.2 MARKET SHARE ANALYSIS
    • 24.2.1 THERMO FISHER SCIENTIFIC
    • 24.2.2 SARTORIUS STEDIM BIOTECH
    • 24.2.3 DANAHER
    • 24.2.4 MERCK KGAA
    • 24.2.5 AVANTOR

25 KEY COMPANY PROFILES

  • 25.1 THERMO FISHER SCIENTIFIC
    • 25.1.1 BUSINESS OVERVIEW
    • 25.1.2 PRODUCT OFFERINGS
    • 25.1.3 KEY STRATEGIES
    • 25.1.4 KEY STRENGTHS
    • 25.1.5 KEY OPPORTUNITIES
  • 25.2 SARTORIUS STEDIM BIOTECH
    • 25.2.1 BUSINESS OVERVIEW
    • 25.2.2 PRODUCT OFFERINGS
    • 25.2.3 KEY STRATEGIES
    • 25.2.4 KEY STRENGTHS
    • 25.2.5 KEY OPPORTUNITIES
  • 25.3 DANAHER
    • 25.3.1 BUSINESS OVERVIEW
    • 25.3.2 PRODUCT OFFERINGS
    • 25.3.3 KEY STRATEGIES
    • 25.3.4 KEY STRENGTHS
    • 25.3.5 KEY OPPORTUNITIES
  • 25.4 MERCK KGAA
    • 25.4.1 BUSINESS OVERVIEW
    • 25.4.2 PRODUCT OFFERINGS
    • 25.4.3 KEY STRATEGIES
    • 25.4.4 KEY STRENGTHS
    • 25.4.5 KEY OPPORTUNITIES
  • 25.5 AVANTOR
    • 25.5.1 BUSINESS OVERVIEW
    • 25.5.2 PRODUCT OFFERINGS
    • 25.5.3 KEY STRATEGIES
    • 25.5.4 KEY STRENGTHS
    • 25.5.5 KEY OPPORTUNITIES

26 OTHER PROMINENT VENDORS

  • 26.1 3I GROUP
    • 26.1.1 BUSINESS OVERVIEW
    • 26.1.2 PRODUCT OFFERINGS
  • 26.2 3M
    • 26.2.1 BUSINESS OVERVIEW
    • 26.2.2 PRODUCT OFFERINGS
  • 26.3 ABEC
    • 26.3.1 BUSINESS OVERVIEW
    • 26.3.2 PRODUCT OFFERINGS
  • 26.4 ADOLF KUHNER
    • 26.4.1 BUSINESS OVERVIEW
    • 26.4.2 PRODUCT OFFERINGS
  • 26.5 ADVANTAPURE
    • 26.5.1 BUSINESS OVERVIEW
    • 26.5.2 PRODUCT OFFERINGS
  • 26.6 BARRY-WEHMILLER COMPANIES
    • 26.6.1 BUSINESS OVERVIEW
    • 26.6.2 PRODUCT OFFERING
  • 26.7 BROADLEY-JAMES
    • 26.7.1 BUSINESS OVERVIEW
    • 26.7.2 PRODUCT OFFERINGS
  • 26.8 CELLTAINER BIOTECH
    • 26.8.1 BUSINESS OVERVIEW
    • 26.8.2 PRODUCT OFFERINGS
  • 26.9 CERCELL A/S
    • 26.9.1 BUSINESS OVERVIEW
    • 26.9.2 PRODUCT OFFERINGS
  • 26.10 CESCO BIOENGINEERING
    • 26.10.1 BUSINESS OVERVIEW
    • 26.10.2 PRODUCT OFFERINGS
  • 26.11 CHARTER MEDICAL
    • 26.11.1 BUSINESS OVERVIEW
    • 26.11.2 PRODUCT OFFERINGS
  • 26.12 COLDER PRODUCTS COMPANY
    • 26.12.1 BUSINESS OVERVIEW
    • 26.12.2 PRODUCT OFFERINGS
  • 26.13 CORNING
    • 26.13.1 BUSINESS OVERVIEW
    • 26.13.2 PRODUCT OFFERINGS
  • 26.14 DISTEK
    • 26.14.1 BUSINESS OVERVIEW
    • 26.14.2 PRODUCT OFFERINGS
  • 26.15 DRM, DR. MUELLER
    • 26.15.1 BUSINESS OVERVIEW
    • 26.15.2 PRODUCT OFFERINGS
  • 26.16 EMERSON ELECTRIC
    • 26.16.1 BUSINESS OVERVIEW
    • 26.16.2 PRODUCT OFFERINGS
  • 26.17 ENTEGRIS
    • 26.17.1 BUSINESS OVERVIEW
    • 26.17.2 PRODUCT OFFERINGS
  • 26.18 EPPENDORF
    • 26.18.1 BUSINESS OVERVIEW
    • 26.18.2 PRODUCT OFFERINGS
  • 26.19 FOXX LIFE SCIENCES
    • 26.19.1 BUSINESS OVERVIEW
    • 26.19.2 PRODUCT OFFERINGS
  • 26.20 GETINGE
    • 26.20.1 BUSINESS OVERVIEW
    • 26.20.2 PRODUCT OFFERINGS
  • 26.21 HIGH-PURITY NEW ENGLAND
    • 26.21.1 BUSINESS OVERVIEW
    • 26.21.2 PRODUCT OFFERINGS
  • 26.22 HOLLAND APPLIED TECHNOLOGIES
    • 26.22.1 BUSINESS OVERVIEW
    • 26.22.2 PRODUCT OFFERINGS
  • 26.23 LONZA
    • 26.23.1 BUSINESS OVERVIEW
    • 26.23.2 PRODUCT OFFERINGS
  • 26.24 MEISSNER FILTRATION PRODUCTS
    • 26.24.1 BUSINESS OVERVIEW
    • 26.24.2 PRODUCT OFFERINGS
  • 26.25 NEW HORIZON BIOTECH
    • 26.25.1 BUSINESS OVERVIEW
    • 26.25.2 PRODUCT OFFERINGS
  • 26.26 OMNIBRX BIOTECHNOLOGIES
    • 26.26.1 BUSINESS OVERVIEW
    • 26.26.2 PRODUCT OFFERINGS
  • 26.27 PARKER HANNIFIN
    • 26.27.1 BUSINESS OVERVIEW
    • 26.27.2 PRODUCT OFFERINGS
  • 26.28 PENDOTECH
    • 26.28.1 BUSINESS OVERVIEW
    • 26.28.2 PRODUCT OFFERINGS
  • 26.29 PBS BIOTECH
    • 26.29.1 BUSINESS OVERVIEW
    • 26.29.2 PRODUCT OFFERINGS
  • 26.30 REPLIGEN
    • 26.30.1 BUSINESS OVERVIEW
    • 26.30.2 PRODUCT OFFERINGS
  • 26.31 SAINT-GOBAIN
    • 26.31.1 BUSINESS OVERVIEW
    • 26.31.2 PRODUCT OFFERINGS
  • 26.32 SENTINEL PROCESS SYSTEMS
    • 26.32.1 BUSINESS OVERVIEW
    • 26.32.2 PRODUCT OFFERINGS
  • 26.33 SOLARIS BIOTECHNOLOGY
    • 26.33.1 BUSINESS OVERVIEW
    • 26.33.2 PRODUCT OFFERINGS
  • 26.34 SYSBIOTECH
    • 26.34.1 BUSINESS OVERVIEW
    • 26.34.2 PRODUCT OFFERINGS
  • 26.35 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
    • 26.35.1 BUSINESS OVERVIEW
    • 26.35.2 PRODUCT OFFERINGS
  • 26.36 WEIGAO GROUP
    • 26.36.1 BUSINESS OVERVIEW
    • 26.36.2 PRODUCT OFFERINGS
  • 26.37 W.L. GORE & ASSOCIATES
    • 26.37.1 BUSINESS OVERVIEW
    • 26.37.2 PRODUCT OFFERINGS

27 REPORT SUMMARY

  • 27.1 KEY TAKEAWAYS
  • 27.2 STRATEGIC RECOMMENDATIONS

28 QUANTITATIVE SUMMARY

  • 28.1 MARKET BY PRODUCT TYPE
    • 28.1.1 NORTH AMERICA MARKET BY PRODUCT TYPE
    • 28.1.2 EUROPE MARKET BY PRODUCT TYPE
    • 28.1.3 APAC MARKET BY PRODUCT TYPE
    • 28.1.4 LATIN AMERICA MARKET BY PRODUCT TYPE
    • 28.1.5 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
  • 28.2 MARKET BY APPLICATION
    • 28.2.1 NORTH AMERICA MARKET BY APPLICATION
    • 28.2.2 EUROPE MARKET BY APPLICATION
    • 28.2.3 APAC MARKET BY APPLICATION
    • 28.2.4 LATIN AMERICA MARKET BY APPLICATION
    • 28.2.5 MIDDLE EAST & AFRICA MARKET BY APPLICATION
  • 28.3 MARKET BY END-USER
    • 28.3.1 NORTH AMERICA MARKET BY END-USER
    • 28.3.2 EUROPE MARKET BY END-USER
    • 28.3.3 APAC MARKET BY END-USER
    • 28.3.4 LATIN AMERICA MARKET BY END-USER
    • 28.3.5 MIDDLE EAST & AFRICA MARKET BY END-USER
  • 28.4 MARKET BY METHOD
  • 28.5 MARKET BY WORKFLOW
  • 28.6 MARKET BY GEOGRAPHY
    • 28.6.1 SINGLE-USE BIOPROCESSING EQUIPMENT MARKET BY GEOGRAPHY
    • 28.6.2 SIMPLE & PERIPHERAL DEVICES MARKET BY GEOGRAPHY
    • 28.6.3 MONOCLONAL ANTIBODIES (MABS) MARKET BY GEOGRAPHY
    • 28.6.4 VACCINES MARKET BY GEOGRAPHY
    • 28.6.5 CELL THERAPIES MARKET BY GEOGRAPHY
    • 28.6.6 OTHERS MARKET BY GEOGRAPHY
    • 28.6.7 BIOPHARMACEUTICAL MANUFACTURERS MARKET BY GEOGRAPHY
    • 28.6.8 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET BY GEOGRAPHY
    • 28.6.9 R&D COMPANIES AND RESEARCH INSTITUTES MARKET BY GEOGRAPHY

29 APPENDIX

  • 29.1 ABBREVIATIONS